Cite
HARVARD Citation
Carlo‐Stella, C. et al. (2023). A phase 1/2, open‐label, multicenter study of isatuximab in combination with cemiplimab in patients with lymphoma. Hematological oncology. 41 (1), pp. 108-119. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Carlo‐Stella, C. et al. (2023). A phase 1/2, open‐label, multicenter study of isatuximab in combination with cemiplimab in patients with lymphoma. Hematological oncology. 41 (1), pp. 108-119. [Online].